Pharmaceuticals

Fighting Diseases

Latest News
September 26, 2022
Not intended for U.S. and UK Media
Eylea® approved in Japan for treatment of preterm infants with retinopathy of prematurity
September 20, 2022
Not intended for U.S. and UK Media - EASD Congress 2022:
Bayer to present new cardiorenal data for Kerendia™ (finerenone) across a broad range of patients with early to late-stage chronic kidney disease and type 2 diabetes
September 11, 2022
Not intended for U.S. and UK Media – ESMO Congress 2022
New ARASENS data reinforce strong tolerability profile of darolutamide plus ADT and docetaxel without compromising quality of life for patients with mHSPC